Screening mammography: Sensitivity and specificity in relation to hormone replacement therapy

Radiology

Volumn 203, Issue 2, 1997, Pages 339-341

  Thurfjell, Erik L ^a   Holmberg, Lars H ^a   Persson, Ingemar R ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast neoplasms; Breast radiography; Cancer screening; Hormones

Indexed keywords

ESTRADIOL; GESTAGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS;

EID: 0030909910     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.203.2.9114085     Document Type: Article

References (19)

1. Laya MB, Larson EB, Taplin SH, White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88:643-649.
2. Bergkvist L, Tabár L, Adami HO, Persson I, Bergström R. Mammographic parenchymal pattern in women receiving non-contraceptive estrogen treatment. Am J Epidemiol 1989; 130:503-510.
3. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174:487-490.
4. Kaufman Z, Garstin WI, Hayes R, Michell MJ, Baum M. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 1991; 43: 389-392.
5. Cyrlak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. AJR 1993; 161:1177-1183.
6. McNicholas MM, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR 1994; 163:311-315.
7. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995; 196: 433-437.
8. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 1992; 84:781-785.
9. Jackson VP, Hendrick RE, Feig SA, Kopans DB. Imaging of the radiographically dense breast. Radiology 1993; 188:297-301.
10. Feig SA. Hormonal reduction of mammographic densities: potential effects on breast cancer risk and performance of diagnostic and screening mammography. J Natl Cancer Inst 1994; 86:408-409.
11. Wiklund I, Karlberg J, Mattsson LÅ. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993; 168:824-830.
12. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
13. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7:178-208.
14. Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 1993; 15:66-79.
15. Stanford JL, Thomas DB. Exogenous progestins and breast cancer. Epidemiol Rev 1993; 15:98-107.
16. Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer 1994; 74:1111-1124.
17. Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer. Cancer Causes Control 1994; 5:491-500.
18. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589-1593.
19. Thurfjell EL, Lindgren JAA. Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala county. Radiology 1994; 193:351-357.